<DOC>
	<DOCNO>NCT02826941</DOCNO>
	<brief_summary>This study multicenter , randomize , control pilot trial moderate systemic hypothermia ( 33°C ) v normothermia ( 37°C ) 48 hour infant neonatal encephalopathy institute within 6 hour birth hypoxic-ischemic event .</brief_summary>
	<brief_title>Moderate Hypothermia Neonatal Hypoxic Ischemic Encephalopathy</brief_title>
	<detailed_description>The trial test ability initiate systemic hypothermia outlying hospital participate tertiary care center , determine incidence adverse neurologic outcome death developmental score 12 month Bayley II Vineland test normothermic hypothermic group . This trial identify potential safety outcome , compare adverse effect hypothermia among hypoxic-ischemic encephalopathy ( HIE ) infant normothermic hypothermic treatment group , obtain rate adverse outcome .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Hypoxia-Ischemia , Brain</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>One clinical indication hypoxicischemic injury cord gas pH ≤ 7.0 base deficit ≥13 , initial infant gas pH &lt; 7.1 , Apgar score ≤5 10 minute , continue resuscitation 5 min , fetal bradycardia heart rate &lt; 80 beat per minute last ≥15 min , postnatal event O2 sit &lt; 70 % arterial O2 &lt; 35 20 min ischemia And two neurologic finding neonatal encephalopathy , abnormality : tone , reflex , state consciousness , seizure , posturing , autonomic dysfunction Maternal chorioamnionitis , sepsis birth , birth weight head circumference &lt; 10 % , presume chromosomal abnormality</criteria>
	<gender>All</gender>
	<minimum_age>35 Weeks</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hypothermia treatment</keyword>
</DOC>